Dr Joseph Albert Mendiola, DNP, ACNPC-AG, RN | |
110 Irving St Nw, Washington, DC 20010-3017 | |
(202) 877-7462 | |
Not Available |
Full Name | Dr Joseph Albert Mendiola |
---|---|
Gender | Male |
Speciality | Nurse Practitioner |
Experience | 6 Years |
Location | 110 Irving St Nw, Washington, District Of Columbia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023597671 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LA2100X | Nurse Practitioner - Acute Care | RN1049423 (District Of Columbia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Medstar Washington Hospital Center | Washington, DC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medstar Medical Group Ii Llc | 0547413825 | 1776 |
Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
NicOx S.A. today announced that a Marketing Authorization Application (MAA) for naproxcinod has been submitted to the European Medicines Agency (EMEA) through the centralized procedure, seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA).
Rose Medical Center is the first hospital in Colorado to perform a new and innovative procedure for patients with peripheral arterial disease (PAD). Utilizing the Lutonix 035 Drug Coated Balloon PTA Catheter, surgeons are able to perform a balloon angioplasty in patients with PAD using a special drug-coated balloon (DCB) that delivers a small amount of medication to the inside walls of the diseased portion of the artery.
A new service is being launched today: wound care teleassistance, also known as téléassistance en soins de plaies (TASP). With this service a nurse can use a camera to film her patient's wound, while at the same time an expert nurse in another institution can receive the images. They can then hold an online discussion to evaluate the patient's wound and plan treatment.
Cerenis Therapeutics SA, a privately held biopharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, today announced it will present the results of two clinical proof-of-concept studies for its CER-627 program (niacin/aspirin combinations) at the 78th European Atherosclerosis Society Congress on June 20-23 in Hamburg, Germany.
Mutations in the adenomatous polyposis coli (APC) tumor suppressor gene have been found to cause 85 percent of colon cancers.
› Verified 1 days ago
Entity Name | Washington Hospital Center Corp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407870124 PECOS PAC ID: 3577476266 Enrollment ID: O20040630000173 |
News Archive
NicOx S.A. today announced that a Marketing Authorization Application (MAA) for naproxcinod has been submitted to the European Medicines Agency (EMEA) through the centralized procedure, seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA).
Rose Medical Center is the first hospital in Colorado to perform a new and innovative procedure for patients with peripheral arterial disease (PAD). Utilizing the Lutonix 035 Drug Coated Balloon PTA Catheter, surgeons are able to perform a balloon angioplasty in patients with PAD using a special drug-coated balloon (DCB) that delivers a small amount of medication to the inside walls of the diseased portion of the artery.
A new service is being launched today: wound care teleassistance, also known as téléassistance en soins de plaies (TASP). With this service a nurse can use a camera to film her patient's wound, while at the same time an expert nurse in another institution can receive the images. They can then hold an online discussion to evaluate the patient's wound and plan treatment.
Cerenis Therapeutics SA, a privately held biopharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, today announced it will present the results of two clinical proof-of-concept studies for its CER-627 program (niacin/aspirin combinations) at the 78th European Atherosclerosis Society Congress on June 20-23 in Hamburg, Germany.
Mutations in the adenomatous polyposis coli (APC) tumor suppressor gene have been found to cause 85 percent of colon cancers.
› Verified 1 days ago
Entity Name | Medstar Medical Group Ii Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000415 |
News Archive
NicOx S.A. today announced that a Marketing Authorization Application (MAA) for naproxcinod has been submitted to the European Medicines Agency (EMEA) through the centralized procedure, seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA).
Rose Medical Center is the first hospital in Colorado to perform a new and innovative procedure for patients with peripheral arterial disease (PAD). Utilizing the Lutonix 035 Drug Coated Balloon PTA Catheter, surgeons are able to perform a balloon angioplasty in patients with PAD using a special drug-coated balloon (DCB) that delivers a small amount of medication to the inside walls of the diseased portion of the artery.
A new service is being launched today: wound care teleassistance, also known as téléassistance en soins de plaies (TASP). With this service a nurse can use a camera to film her patient's wound, while at the same time an expert nurse in another institution can receive the images. They can then hold an online discussion to evaluate the patient's wound and plan treatment.
Cerenis Therapeutics SA, a privately held biopharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, today announced it will present the results of two clinical proof-of-concept studies for its CER-627 program (niacin/aspirin combinations) at the 78th European Atherosclerosis Society Congress on June 20-23 in Hamburg, Germany.
Mutations in the adenomatous polyposis coli (APC) tumor suppressor gene have been found to cause 85 percent of colon cancers.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Joseph Albert Mendiola, DNP, ACNPC-AG, RN 3822 Stepping Stone Ln, Burtonsville, MD 20866-1935 Ph: (301) 275-0895 | Dr Joseph Albert Mendiola, DNP, ACNPC-AG, RN 110 Irving St Nw, Washington, DC 20010-3017 Ph: (202) 877-7462 |
News Archive
NicOx S.A. today announced that a Marketing Authorization Application (MAA) for naproxcinod has been submitted to the European Medicines Agency (EMEA) through the centralized procedure, seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA).
Rose Medical Center is the first hospital in Colorado to perform a new and innovative procedure for patients with peripheral arterial disease (PAD). Utilizing the Lutonix 035 Drug Coated Balloon PTA Catheter, surgeons are able to perform a balloon angioplasty in patients with PAD using a special drug-coated balloon (DCB) that delivers a small amount of medication to the inside walls of the diseased portion of the artery.
A new service is being launched today: wound care teleassistance, also known as téléassistance en soins de plaies (TASP). With this service a nurse can use a camera to film her patient's wound, while at the same time an expert nurse in another institution can receive the images. They can then hold an online discussion to evaluate the patient's wound and plan treatment.
Cerenis Therapeutics SA, a privately held biopharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, today announced it will present the results of two clinical proof-of-concept studies for its CER-627 program (niacin/aspirin combinations) at the 78th European Atherosclerosis Society Congress on June 20-23 in Hamburg, Germany.
Mutations in the adenomatous polyposis coli (APC) tumor suppressor gene have been found to cause 85 percent of colon cancers.
› Verified 1 days ago
Ms. Janet E Jumper, N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, 4b42, Washington, DC 20010 Phone: 202-877-7462 | |
Arlyne E Heerlein, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Us Dept Ofstate, 2401 E St., Nw, Washington, DC 20522 Phone: 202-663-2453 Fax: 202-663-3247 | |
Seble Yirga, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-7265 Fax: 202-444-4208 | |
Daniel Richard Stairiker, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw, Washington, DC 20016 Phone: 202-537-4000 | |
Monica Elston, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw # 3phc, Washington, DC 20007 Phone: 202-444-8531 | |
Sarah Katkhouda, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1627 I St Nw Ste 800, Washington, DC 20006 Phone: 202-204-7092 | |
Ms. Desiree Rivas, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 220 I St Ne, Washington, DC 20002 Phone: 703-867-2503 |